Exchange: NASDAQ·Updated 09:30 AM EDT

AAPG Ascentage Pharma Group International - ADR

$16.71
$0.56
(3.35%)
Pre-Market
Prev Close $16.71
EarningsMar 25
Mkt Cap$1.55B
Vol107.00

About AAPG

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
68

Bullish Sentiment

How do you feel about AAPG?

Advertisement|Remove ads.